Stocks › CDNA
CareDx, Inc.
CDNA·Nasdaq·
United States·USD
United States·USD$63.79
-6.06 (-8.68%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CDNA
CareDx, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CDNAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CDNA by members of U.S. Congress · 14 on record
Whale Activity
Position changes in CDNA reported for 2026-06-30 by 12 tracked institutional filers
- Increased7
- New1
- Held0
- Decreased0
- Closed0
- No prior filing4
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 4.8M | $137.2M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $62.6M | increased |
| RENAISSANCE TECHNOLOGIES LLC | 1.2M | $35.4M | increased |
| D. E. Shaw & Co., Inc. | 1.1M | $32.4M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 989.5K | $28.2M | increased |
| Palo Alto Investors LP | 531.9K | $15.2M | — |
| TWO SIGMA INVESTMENTS, LP | 402.0K | $11.5M | increased |
| CITADEL ADVISORS LLC | 107.0K | $3.0M | increased |
| FORMULA GROWTH LTD | 78.0K | $2.2M | — |
| MILLENNIUM MANAGEMENT LLC | 73.8K | $2.1M | new |
| Knott David M Jr | 13.6K | $388K | — |
| Bullseye Asset Management LLC | 203.7K | $6K | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CDNA insiders, by quarter · Form 4
Recent Insider Transactions
1,250 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Novack Jeffrey AdamSecretary and General Counsel | Sale | −500 | $46.75 | $23K | Aug 5, 2026 | Form 4 ↗ |
| Novack Jeffrey AdamSecretary and General Counsel | Sale | −2,188 | $46.15 | $101K | Aug 5, 2026 | Form 4 ↗ |
| Bickerstaff GeorgeDirector · Director | Sale | −20.0K | $46.28 | $926K | Aug 5, 2026 | Form 4 ↗ |
| Goldberg MichaelDirector · Director | Sale | −44.7K | $47.06 | $2.1M | Aug 4, 2026 | Form 4 ↗ |
| COURNOYER CHRISTINEDirector · Director | Sale | −16.0K | $46.94 | $751K | Aug 4, 2026 | Form 4 ↗ |
| Valantine HannahDirector · Director | Sale | −28.7K | $36.14 | $1.0M | Jul 16, 2026 | Form 4 ↗ |
| Valantine HannahDirector · Director | Sale | −100 | $36.55 | $4K | Jul 16, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Sale | −68.0K | $39.01 | $2.7M | Jul 16, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Sale | −50.0K | $36.11 | $1.8M | Jul 16, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Sale | −39.9K | $29.24 | $1.2M | Jun 29, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Option exercise | +39.9K | $8.20 | $327K | Jun 29, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Sale | −100 | $29.00 | $3K | Jun 26, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Option exercise | +100 | $8.20 | $820 | Jun 26, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Option exercise | +15.7K | $8.20 | $129K | Jun 15, 2026 | Form 4 ↗ |
| Hanna John Walter JRPresident and CEO · Director | Sale | −17.7K | $24.03 | $425K | Jun 15, 2026 | Form 4 ↗ |
| Valantine HannahDirector | Sale | −12.1K | $23.11 | $280K | Jun 15, 2026 | Form 4 ↗ |
| Gunasekaran SureshDirector | Grant / award | +9,795 | $0.00 | $0 | Jun 12, 2026 | Form 4 ↗ |
| Valantine HannahDirector | Grant / award | +9,795 | $0.00 | $0 | Jun 12, 2026 | Form 4 ↗ |
| Riggsbee Richard BryanDirector | Grant / award | +9,795 | $0.00 | $0 | Jun 12, 2026 | Form 4 ↗ |
| Goldberg MichaelDirector | Grant / award | +9,795 | $0.00 | $0 | Jun 12, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CDNA · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| ARK Genomic Revolution ETF ARK ETF Trust | 1.5M | $66.9M | 4.30% | Jul 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.6M | $44.3M | 0.00% | Jun 30, 2026 |
| BARON DISCOVERY FUND BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 1.4M | $39.1M | 2.14% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.3M | $38.2M | 0.05% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.1M | $32.6M | 0.30% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 560.8K | $24.5M | 0.07% | Jul 31, 2026 |
| First Eagle Small Cap Opportunity Fund First Eagle Funds | 485.1K | $21.2M | 0.73% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 588.5K | $16.8M | 0.02% | Jun 30, 2026 |
| Column Small Cap Select Fund Trust for Professional Managers | 651.8K | $14.9M | 0.79% | May 31, 2026 |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 325.2K | $14.2M | 5.04% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list CDNA's shares (CUSIP 14167L103), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Baron Capital Management, Inc.SCHEDULE 13G/A · passive (13G) · 274.4K shares0.5%
Aug 14, 2026 · ↗ - Ronald BaronSCHEDULE 13G/A · passive (13G) · 1.9M shares3.8%
Aug 14, 2026 · ↗ - Baron Capital Group, Inc.SCHEDULE 13G/A · passive (13G) · 1.9M shares3.8%
Aug 14, 2026 · ↗ - BAMCO INC /NY/SCHEDULE 13G/A · passive (13G) · 1.7M shares3.2%
Aug 14, 2026 · ↗ - Neil GagnonSCHEDULE 13G/A · passive (13G) · 2.3M shares4.4%
Aug 7, 2026 · ↗ - Gagnon Advisors, LLCSCHEDULE 13G/A · passive (13G) · 408.8K shares0.8%
Aug 7, 2026 · ↗ - Gagnon Securities LLCSCHEDULE 13G/A · passive (13G) · 1.6M shares3.2%
Aug 7, 2026 · ↗ - STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 2.5M shares4.8%
Aug 7, 2026 · ↗ - BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 4.7M shares9.0%
Jul 27, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming caredx as client
Government Contracts
Federal awards to caredx · USAspending
$6.4MAwarded · 5 contracts on record
- Department of Veterans AffairsLAB TESTS FOR POST TRANSPLANT CARE.$1.6M
Apr 1, 2026 · ↗ - Department of Veterans AffairsTRANSPLANT TESTING KITS$2.5M
Sep 29, 2026 · ↗ - Department of Veterans AffairsGENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)$1.0M
Sep 23, 2026 · ↗ - Department of Veterans AffairsALLOSURE KIDNEY TEST$171K
Oct 19, 2022 · ↗ - Department of Veterans AffairsALLOMAP AND ALLOSURE POST HEART TRANSPLANT REJECTION SURVEILLANCE TESTS SERVICES$1.1M
Mar 1, 2022 · ↗
U.S. Patents
Recent USPTO applications naming CareDx, Inc.
No USPTO patent applications found for CareDx, Inc..
Annual Financials
From CDNA's 10-K filings · XBRL
No annual XBRL figures on record for CDNA. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CDNA's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K/A · Items 2.01, 9.01Acquisition or dispositionSep 16, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 30, 2026
EDGAR ↗ - 8-K · Items 2.01, 7.01, 9.01Acquisition or disposition · Reg FD disclosureJul 7, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 15, 2026
EDGAR ↗
About CareDx, Inc.
From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersBRISBANE, CA
IncorporatedDE
SEC CIK0001217234 ↗
Former namesXDx, Inc., EXPRESSION DIAGNOSTICS INC